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Sequencing of 16S rDNA, and of sodAint and rpoBint in
some cases, was applied to DNA from heart valves of 46
patients (36 with definite and 10 with possible endocardi-
tis). Sequence-based identifications were compared with
those obtained with conventional methods. Among the 36
definite cases, 30 had positive blood cultures and 6 had
negative cultures. Among the 30 positive cases, sequenc-
ing of 16S rDNA permitted identification of species (18),
genus (8), or neither (4); sodAint and  rpoBint sequencing
was necessary for species identification in 8 cases.
Species identifications were identical in only 61.5%, when
conventional techniques and DNA sequencing were used.
In five of the six blood culture–negative endocarditis cases,
sequencing identified Bartonella quintana (3), B. henselae
(1), and Streptococcus gallolyticus (1). Our results demon-
strate a clear benefit of molecular identification, particularly
in cases of blood culture–negative endocarditis and of pos-
sible endocarditis, to confirm or invalidate the diagnosis.
Moreover, in 19.4% of the definite cases, the improvement
in species identification by sequencing led to improved
patient management. 
A
ccording to the earliest published report on the sub-
ject, the prevalence of blood culture-negative endo-
carditis once ranged from 2.5% to 31% (1). In more recent
studies, approximately 9% is the reported rate (2). One
explanation for the improvement in the bacteriologic diag-
nosis of endocarditis is better knowledge of its clinical
symptoms and risk factors, which has encouraged earlier
blood culture. Another reason is the improvement in bacte-
rial culture techniques, with prolonged incubation times,
presence of carbon dioxide, enriched culture media, and
timed subcultures. Thus, the isolation of fastidious
microorganisms including Abiotrophia (new genus
Granulicatella) and the HACEK group, has improved dra-
matically, and organisms frequently missed with the use of
earlier blood culture techniques are now recognized.
Another improvement is the use of specific serologic tests
for certain microorganisms. Such tests, associated with cell
cultures, are now recommended for patients with blood
culture-negative endocarditis for which Coxiella burnetii
and Bartonella spp. are the suspected causative organisms
(3–5). Despite these improvements, the diagnosis of blood
culture–negative endocarditis remains a challenge. The
absence of positive culture is most frequently due to previ-
ous antimicrobial drug treatment or to bacterial species
that are difficult to grow or that remain nonculturable in
the laboratory. 
To overcome these problems, molecular techniques
using broad-range DNA primers for amplification of bac-
terial 16S rDNA directly from clinical samples and subse-
quent nucleotide sequencing (6,7) have been proposed to
establish the infectious etiology (8–10). This approach,
combined with sodAint, encoding superoxide dismutase
(11) and rpoBint, encoding the β sub-unit of RNA poly-
merase (12) sequencing when 16S rDNA sequences were
not sufficiently discriminating, was used here 1) to evalu-
ate the bacterial content of 46 resected heart valves from
patients operated on for endocarditis, 2) to compare the
results with bacteriologic and histologic findings from
heart valves and from preceding blood cultures, and 3) to
analyze the data with respect to the clinical background of
the patients, including the modified Duke criteria (13).
Patients and Methods
Patients
From October 2000 to June 2002, all patients operated
on for endocarditis at the Hôpital Européen Georges
Pompidou, Paris, were classified according to the modified
Duke criteria for the diagnosis of infective endocarditis
(13). We studied a total of 46 cases (26 men and 20 women;
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clinically definite (31 native valves and 5 prostheses) and
10 clinically possible (5 native valves and 5 prostheses)
cases. Among the 36 definite cases, 27 patients had two
major criteria, and 9 patients had one major and three minor
criteria. All 10 patients classified as having possible endo-
carditis had one major and one minor criterion. Thirty-two
(69.5%) of the 46 patients had been transferred to our hos-
pital for surgery. In these cases, blood cultures and conven-
tional bacterial identification had been performed in other
hospitals (23 hospitals, including 3 in foreign countries).
Twenty-five patients without endocarditis who were oper-
ated on for valve replacement were studied as controls. 
Microbiologic Methods
The excised heart valves were processed under a lami-
nar flow hood. Portions of abnormal valve tissue were
ground with a mortar and pestle and cultured on Columbia
sheep blood agar, and chocolate agar supplemented with
IsoVitaleX (bioMérieux, Marcy l’Etoile, France) (at 37°C
aerobically and with 5% CO2 for 10 days), Schaedler
sheep blood agar (at 37°C anaerobically for 10 days), brain
heart infusion broth, and brain heart infusion broth supple-
mented with IsoVitaleX (aerobically at 37°C for 30 days).
In each case, a valve culture was also performed in an
anaerobic blood culture vial (Vital, bioMérieux), which
was incubated for 1 month at 37°C. A direct Gram (and
Giménez if necessary) stain was performed. Bacteria from
isolated colonies were identified according to standard pro-
cedures (14). Heart valve samples were stored at –80°C
before DNA extraction. When bacteria were isolated from
blood cultures in our hospital, they were identified accord-
ing to standard procedures (14).
Molecular Methods
DNA Extraction
DNA extractions and polymerase chain reactions (PCR)
were carried out in separate areas. DNA from heart valve
material was extracted (two parallel extractions per valve),
according to the manufacturer’s instructions, with the
QIAMPTissue Kit (Qiagen, Courtaboeuf, France). For each
batch of extraction, a negative extraction control containing
all reagents except heart valve material was included.
PCR Amplification
For each specimen, DNA in 2 V of crude extract (5 µL
and 20 µL) was directly amplified with one or two sets of
primers (p13B and p91E or p13B and p515FPL), as
described previously for 16S rDNA (15), with d1 and d2
for sodAint (11) and with CM7 and CM31b for rpoBint (12).
Reaction mixes (50 µL) were set up with two Taq DNA
polymerases (Superpak, Sigma, St. Louis, MO, and
Qbiogen, Illkirch, France), according to the specifications
of the manufacturers, and 0.2 µM of each appropriate
primer. For each batch of six samples, two negative con-
trols were included. PCR was performed in a PTC 200
thermocycler (VWR International, Fontenay-sous-Bois,
France) with the following thermal cycling parameters for
16S rDNA: 94°C for 2 min, followed by 35 cycles at 94°C
for 30 s, 56°C for 1 min, and 72°C for 1 min, followed by
a final extension at 72°C for 10 min. When the PCR result
was negative, an amplification of the human β-globin gene
was performed as an internal extraction control. Sequence
analysis of both strands was carried out on a 3700 DNA
analyzer (Applied Biosystems, Courtaboeuf, France).
Similarity searches were carried out against GenBank and
the Ribosomal Database Project (RDP II, Michigan State
University, East Lansing, MI).
Histologic Analysis
Pieces of formalin-fixed abnormal valve tissue were
examined. Paraffin sections were cut and stained with
hematoxylin and eosin and Gram (and Giménez if neces-
sary) stains. The histopathologic diagnosis was based on
valvular inflammation, vegetation, microorganisms, or
other features consistent with endocarditis (16).
Results
Among the 46 cases of endocarditis, 36 were identified
before surgery as definite and 10 as possible, according to
the modified Duke criteria (13).
Definite Endocarditis
Among the 36 cases of definite endocarditis, blood cul-
tures were positive in 30 and negative in six (Table). After
surgery, histopathologic criteria were present in all clini-
cally definite cases.
Blood Culture–Positive Patients
PCR amplification of the bacterial 16S rDNA directly
from the resected valves of the 30 patients with positive
blood cultures was positive in 26 cases and negative in 4
(Table). The mean duration of antimicrobial drug treatment
before surgery was 24.6 days (range 1–75 days) for the
PCR-positive group and 34.5 days (range 18–53 days) for
the PCR-negative group. In the negative group, three
patients had right-side endocarditis stemming from pace-
maker infection attributable to Staphylococcus epider-
midis,  S. caprae, or an association of S. aureus,
Escherichia coli, and Streptococcus pneumoniae, respec-
tively. The fourth patient had endocarditis on the mitral
valve attributable to Staphylococcus aureus. The direct
examination of valve samples after Gram staining showed
evidence of bacteria in two cases (S. aureus and S. caprae);
culture was positive in only one, yielding S. caprae. 
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ture positive, with the same microorganism as previously
identified in the blood cultures (Escherichia coli, S. aureus
[2],  Propionibacterium acnes, and  Streptococcus mitis).
The mean duration of antimicrobial drug treatment was 8.2
days (range 1–22 days) when the valve culture was posi-
tive and 30.2 days (range 5–75 days) when the valve cul-
ture was negative. There was full agreement in 16 cases
(61.5%) between the bacterial identifications obtained
with conventional methods after blood culture and
sequence-based identifications with DNA extracted from
heart valves (Table). Discrepancies (38.5%, Table) were
due to misidentification at the genus level in three cases,
misidentification of the species in six cases, and absence of
identification to the species level after blood culture in one
case. Overall, there were seven cases in which only sodAint
sequence analysis allowed differentiation between S. mitis,
S. oralis and S. pneumoniae and one case in which rpoB
analysis allowed differentiation between E. coli and other
Enterobacteriacae.
Blood Culture–Negative Patients
In the six cases of negative blood culture (Table), the
patients had been treated with antimicrobial drugs before
surgery; culture of their valves was also negative. The
mean duration of antimicrobial drug treatment was 60 days
(range 45–120 days). In five of the six patients, 16S rDNA
sequencing permitted bacterial identification from the
resected valves. Four of these contained Bartonella (three
B. quintana and one B. henselae). Three of the patients
with  Bartonella  endocarditis were transferred directly
from Africa to our hospital for surgery; primary diagnosis
was performed by PCR and confirmed by subsequent
serology. In the fourth patient, serologic results were posi-
tive before surgery and confirmed by PCR. Serologic test-
ing with a microfluorescence assay showed titers of >1:800
for immunoglobulin G antibodies (5). S. gallolyticus was
identified in the fifth patient, who had been treated with
amoxicillin for a suspected urinary tract infection before
the blood cultures were taken. In the sixth patient (PCR
negative), the histologic results showed a subacute aortic
endocarditis with a single epithelioid granuloma, the cause
of which remained undetermined.
Possible Endocarditis
Ten patients were classified before surgery as having
possible endocarditis (13). In these patients, blood cultures
were negative, and PCR did not indicate a microorganism.
The histologic analysis of the resected valves also did not
indicate any feature of endocarditis, in accordance with the
bacteriologic results. 
Control Patients
Twenty-five patients who were operated on for valve
replacement but who did not have endocarditis were
included as controls. PCR from resected valves and
histopathologic signs were negative in all these patients. 
Discussion
The clinical diagnosis of infective endocarditis, partic-
ularly in patients who have negative blood culture, were
previously treated with antimicrobial drugs, or both, is
generally difficult. In this study of 46 cases of definite or
possible endocarditis, we used amplification of 16S rDNA
extracted from valves and subsequent sequencing to iden-
tify the bacterial agent responsible for endocarditis. The
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Table. Comparison of results obtained from blood cultures with conventional methods of identification (CMI-BC) and  from valves with 
sequence-based identification (SBI-V) 
Positive blood culture (n = 30)  Negative blood culture (n = 6) 
PCR positive (n = 26) 
PCR  
negative (n = 4)
a 
PCR  
positive (n = 5) 
PCR  
negative n = 1 
Species identification  
Concordance (n = 16)  Discordance (n = 10)       
(CMI-BC/SBI-V)  CMI-BC  SBI-V  CMI-BC  SBI-V   
Strep. mutans 
Strep. sanguis 
Strep. gallolyticus (4) 
Campylobacter fetus 
Escherichia coli
b 
Propionibacterium acnes 
Staph. aureus (2) 
Strep.  oralis (2)
c 
Strep. mitis (2)
c 
Strep. pneumoniae
c 
Strep. agalactiae 
Gemella spp. 
Group C streptococci 
Strep. mitis (2) 
Strep. sanguis
 
Strep. salivarius 
Haemophilus influenzae 
H. aphrophilus 
Streptococcus spp.
 
Lactobacillus crispatus 
Aerococcus urinae 
Abiotrophia adiacens 
Strep. sanguis (2) 
Strep. oralis
c 
Strep. oralis
c 
H. aphrophilus 
H. paraphrophilus 
Strep. gordonii 
Staph. aureus 
Staph. epidermidis 
Staph. caprae 
 
Staph. aureus + 
Strep. pneumoniae 
+ E. coli 
 
Strep. gallolyticus  
Bartonella quintana (3) 
B. henselae 
 
 
 
 
aIn the case of positive blood cultures with Staphylococcus (Staph) aureus, Escherichia coli, and Streptococcus (Strep) pneumoniae, PCR was 
positive, but direct sequencing was not interpretable. 
bSpecies identification based on sequence analysis of PCR-amplified rpoBint. 
cSpecies identification based on sequence analysis of PCR-amplified sodAint. 
dThree species were identified in the blood culture. 
  dresults were compared with those obtained with conven-
tional bacteriologic methods of identification after blood
culture. When species identifications based on 16S rDNA
sequencing were ambiguous, PCR amplification and
sequencing of sodAint or rpoBint (in one case) were also
performed.
When we considered the cases of definite endocarditis
with positive blood cultures (Table), there was an agree-
ment of 30% (if one includes the PCR-negative results)
between the bacterial identifications obtained after
sequencing of 16S rDNA extracted from heart valves and
those obtained with conventional techniques after blood
culture. There was agreement of 53.3% when the molecu-
lar identification included the analysis of sodAint to differ-
entiate between S. mitis, S. oralis, and S. pneumoniae (11)
and of rpoBint to differentiate between E. coli and closely
related  Enterobacteriacae (12). Combined sequence
analysis entailed the refinement of genus to species identi-
fication in one case, the revision of species identification
in six, and the revision of genus identification in another
three. In four cases (13.3%), the PCR result was negative
despite positive blood culture (with positive valve culture
in one of them) and histologic results that showed features
suggestive of endocarditis. This finding was most likely
due to the workup of inadequate fractions of the valves
(i.e., in some PCR-positive cases, a positive reaction was
obtained only with one of the two valve fractions).
Multiple fractions should therefore be selected after metic-
ulous macroscopic examination. PCR inhibitors were not
likely present since the control reaction with the β-globin
gene was positive in all cases. Obviously, no identification
can be expected from direct sequencing of PCR products
in the presence of multiple bacterial species, as in one case
encountered in this study.
If species, as opposed to genus identification, may have
only modest consequences on the management of most
patients, for some cases the consequences can be substan-
tial. Here, the identification of Lactobacillus crispatus,
instead of S. agalactiae, led to the search and treatment of
the dental portal of entry and the identification of
Abiotrophia adiacens, instead of group C streptococci;
thus in this last case, the antimicrobial drug treatment was
prolonged. In five of six cases of negative blood culture,
PCR permitted the identification of the responsible
microorganism (Table). The identification of S. gallolyti-
cus in one patient led to the search for and removal of a
precancerous intestinal polyp. In four cases, Bartonella
species were identified and the antimicrobial drug regi-
mens modified with the introduction of gentamicin (17)
and prolonged treatment. 16S rDNA PCR is of particular
diagnostic value when serology has not been performed
and when a serologic test is not available (as in the case of
Tropheryma whippleii). Moreover, we believe that PCR on
resected valves should be performed in patients with posi-
tive blood cultures, under two conditions: 1) in the absence
of species identifications; or 2) if there is a lack of correla-
tion between the putative microbial identification by con-
ventional microbiologic techniques and the clinical signs
and symptoms or course of the endocarditis.
Our study shows that analysis of 16S rDNA extracted
from valves is not beneficial only in cases classified as def-
inite endocarditis. It can also serve as a valuable diagnos-
tic tool to confirm or rule out the suspicion of possible
endocarditis. The results obtained with this method in the
10 cases we describe were in full agreement with the his-
tologic findings, which did not indicate features of infec-
tive endocarditis. All patients for whom negative results
were obtained with conventional and molecular methods
were secondarily reclassified and were rejected following
the Duke’s scheme (13). As a therapeutic consequence, the
use of unjustified antimicrobial drug treatment was
stopped.
We conclude that the diagnosis of bacterial endocardi-
tis may benefit from adding molecular biologic identifica-
tion to conventional identification after standard cultures.
This finding is in agreement with those from a recent study
that analyzed a group of patients similar in size and with
endocarditis due to a comparable set of infectious agents
(18) as well as with our recent observation of C. burnetii,
Staphylococcus lugdunensis, and T. whipplei in culture-
negative valves from endocarditis patients with negative
blood cultures. While no false-positive results were
obtained with the PCR-based approach in our study, few
were false negative. On the other hand, this approach con-
tributes to an improvement in bacterial identification in a
substantial number of cases as well as improvement in
patient management in approximately 20%.
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